These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1882007)

  • 1. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic.
    West R; Hajek P; McNeill A
    Psychopharmacology (Berl); 1991; 104(1):91-6. PubMed ID: 1882007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial.
    Robinson MD; Pettice YL; Smith WA; Cederstrom EA; Sutherland DE; Davis H
    J Am Board Fam Pract; 1992; 5(1):1-9. PubMed ID: 1561909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
    Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
    Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.
    Cinciripini PM; Lapitsky L; Seay S; Wallfisch A; Meyer WJ; van Vunakis H
    J Clin Psychopharmacol; 1995 Jun; 15(3):182-91. PubMed ID: 7635995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
    Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone effect on tobacco withdrawal symptoms: a pilot study.
    Robinson MD; Smith WA; Cederstrom EA; Sutherland DE
    J Am Board Fam Pract; 1991; 4(2):89-94. PubMed ID: 2028830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of ondansetron in smoking cessation.
    West R; Hajek P
    Psychopharmacology (Berl); 1996 Jul; 126(1):95-6. PubMed ID: 8853223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of buspirone in the treatment of opioid withdrawal.
    Buydens-Branchey L; Branchey M; Reel-Brander C
    J Clin Psychopharmacol; 2005 Jun; 25(3):230-6. PubMed ID: 15876901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone use for smoking cessation.
    Farid P; Abate MA
    Ann Pharmacother; 1998 Dec; 32(12):1362-4. PubMed ID: 9876819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.
    Carrão JL; Moreira LB; Fuchs FD
    Eur Arch Psychiatry Clin Neurosci; 2007 Oct; 257(7):383-8. PubMed ID: 17902008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
    Anthenelli RM; Blom TJ; McElroy SL; Keck PE
    Addiction; 2008 Apr; 103(4):687-94. PubMed ID: 18339115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone.
    Murphy SM; Owen R; Tyrer P
    Br J Psychiatry; 1989 Apr; 154():529-34. PubMed ID: 2686797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
    Nanovskaya TN; Oncken C; Fokina VM; Feinn RS; Clark SM; West H; Jain SK; Ahmed MS; Hankins GDV
    Am J Obstet Gynecol; 2017 Apr; 216(4):420.e1-420.e9. PubMed ID: 27890648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study.
    Froeliger B; McConnell PA; Stankeviciute N; McClure EA; Kalivas PW; Gray KM
    Drug Alcohol Depend; 2015 Nov; 156():234-242. PubMed ID: 26454838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients.
    Warner DO; Patten CA; Ames SC; Offord KP; Schroeder DR
    Anesthesiology; 2005 Jun; 102(6):1138-46. PubMed ID: 15915026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms.
    Ussher M; Aveyard P; Reid F; West R; Evans P; Clow A; Hucklebridge F; Fuller J; Ibison J; Steptoe A
    Psychopharmacology (Berl); 2011 Jul; 216(1):43-51. PubMed ID: 21301812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.